With funding from top investors, Gameto is aiming to delay — even eradicate — menopause

A small but growing group is also beginning to focus on menopause, which impacts half the population as whose onset is associated with a long list of health conditions, from higher blood pressure, “bad” cholesterol, and triglycerides, which a form of fat in the blood, to, even more frighteningly, a greater risk of breast cancer, heart disease and osteoporosis. The newest outfit focused on the cause is Gameto, which says it wants to solve the problem of “accelerated” ovarian aging to change the trajectory of women’s health and equality. As explained by the company’s cofounder and CEO, Dina Radenkovic, who studied medicine at University College London and has spent most of her career in computational medicine, ovaries age up to five times faster than any organ in the sense that they stop working far earlier than, say, the liver, or brain, or even skin.